Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 24867-26-3 | MDL No. : | MFCD04973589 |
Formula : | C9H15N5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | IPFIEHIRBSTAKA-UHFFFAOYSA-N |
M.W : | 193.25 | Pubchem ID : | 606255 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.56 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 60.29 |
TPSA : | 81.06 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.9 cm/s |
Log Po/w (iLOGP) : | 1.45 |
Log Po/w (XLOGP3) : | 0.81 |
Log Po/w (WLOGP) : | 0.27 |
Log Po/w (MLOGP) : | 0.74 |
Log Po/w (SILICOS-IT) : | 0.05 |
Consensus Log Po/w : | 0.66 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.8 |
Solubility : | 3.07 mg/ml ; 0.0159 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.09 |
Solubility : | 1.56 mg/ml ; 0.00805 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.66 |
Solubility : | 4.21 mg/ml ; 0.0218 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.1 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 96225-96-6 ]
6-(4-Methylpiperazin-1-yl)pyrimidin-4-amine
Similarity: 0.80
[ 69206-89-9 ]
6-(Piperidin-1-yl)pyrimidin-4-amine
Similarity: 0.70
[ 57005-71-7 ]
2-(4-Methylpiperazin-1-yl)pyrimidin-4-amine
Similarity: 0.68
[ 69206-89-9 ]
6-(Piperidin-1-yl)pyrimidin-4-amine
Similarity: 0.70
[ 91717-22-5 ]
2-Amino-4-piperidino-6-methylpyrimidine
Similarity: 0.67
[ 1179369-48-2 ]
1-(Pyrimidin-2-yl)piperidin-4-amine dihydrochloride
Similarity: 0.67
[ 893755-98-1 ]
1-(Pyrimidin-2-yl)piperidin-4-ol
Similarity: 0.66
[ 1260590-51-9 ]
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
Similarity: 0.64
[ 96225-96-6 ]
6-(4-Methylpiperazin-1-yl)pyrimidin-4-amine
Similarity: 0.80
[ 69206-89-9 ]
6-(Piperidin-1-yl)pyrimidin-4-amine
Similarity: 0.70
[ 57005-71-7 ]
2-(4-Methylpiperazin-1-yl)pyrimidin-4-amine
Similarity: 0.68